Explore our drug delivery technology platforms
We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.
Small Molecule Delivery
We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms.
Protein Delivery
We collaborate with you to provide tailored excipient solutions, drawing on our expertise and product portfolio to speed up formulation development and time to market. Enabling drug delivery through a wide range of highly purified excipients to improve protein formulation stability.
Nucleic Acid Delivery
We develop and manufacture innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
Adjuvant Systems
Your partner for modern vaccine development. Our unique GMP portfolio and outstanding expertise can meet your adjuvant needs. Collaborate with our scientists to create the vaccines of tomorrow.
recent insights:
Formulation challenges in GLP-1 therapeutics: Why excipient purity matters
GLP-1-based peptide therapeutics are transforming the treatment of obesity and type 2 diabetes. As developers race to advance the next generation of these medicines, formulation scientists face a less...
One month countdown until CPHI Europe
In a month’s time, over 20 colleagues spanning sales, marketing, R&D and sustainability will be amongst the action at CPHI Europe 2026 in Milan – one of the most important events in the pharmaceutical...
Experience Croda Pharma in Action at CPHI Europe 2026
At CPHI Europe 2026, we’re bringing the refreshed Croda Pharma brand to life. Our new identity reflects our continued commitment to innovation and partnership, with a focus on helping customers...